289 related articles for article (PubMed ID: 33932697)
1. Chemokine CXCL14; a double-edged sword in cancer development.
Gowhari Shabgah A; Haleem Al-Qaim Z; Markov A; Valerievich Yumashev A; Ezzatifar F; Ahmadi M; Mohammad Gheibihayat S; Gholizadeh Navashenaq J
Int Immunopharmacol; 2021 Aug; 97():107681. PubMed ID: 33932697
[TBL] [Abstract][Full Text] [Related]
2. The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.
Westrich JA; Vermeer DW; Colbert PL; Spanos WC; Pyeon D
Mol Carcinog; 2020 Jul; 59(7):794-806. PubMed ID: 32212206
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
Augsten M; Sjöberg E; Frings O; Vorrink SU; Frijhoff J; Olsson E; Borg Å; Östman A
Cancer Res; 2014 Jun; 74(11):2999-3010. PubMed ID: 24710408
[TBL] [Abstract][Full Text] [Related]
4. C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression.
Yang XY; Ozawa S; Kato Y; Maehata Y; Izukuri K; Ikoma T; Kanamori K; Akasaka T; Suzuki K; Iwabuchi H; Kurata SI; Katoh I; Sakurai T; Kiyono T; Hata RI
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31014014
[TBL] [Abstract][Full Text] [Related]
5. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
[TBL] [Abstract][Full Text] [Related]
6. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
Augsten M; Hägglöf C; Olsson E; Stolz C; Tsagozis P; Levchenko T; Frederick MJ; Borg A; Micke P; Egevad L; Ostman A
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3414-9. PubMed ID: 19218429
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals.
Hara T; Tanegashima K
J Biochem; 2012 May; 151(5):469-76. PubMed ID: 22437940
[TBL] [Abstract][Full Text] [Related]
9. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract][Full Text] [Related]
10. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
11. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
Wang H; Nan S; Wang Y; Xu C
J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
[TBL] [Abstract][Full Text] [Related]
12. The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy.
Giacobbi NS; Mullapudi S; Nabors H; Pyeon D
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400076
[TBL] [Abstract][Full Text] [Related]
13. CXCL14 expression and potential function in pancreatic cancer.
Wente MN; Mayer C; Gaida MM; Michalski CW; Giese T; Bergmann F; Giese NA; Büchler MW; Friess H
Cancer Lett; 2008 Feb; 259(2):209-17. PubMed ID: 18054154
[TBL] [Abstract][Full Text] [Related]
14. CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity.
Tanegashima K; Takahashi R; Nuriya H; Iwase R; Naruse N; Tsuji K; Shigenaga A; Otaka A; Hara T
EBioMedicine; 2017 Oct; 24():247-256. PubMed ID: 28928016
[TBL] [Abstract][Full Text] [Related]
15. CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner.
Gibbs C; So JY; Ahad A; Michalowski AM; Son DS; Li Y
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012586
[TBL] [Abstract][Full Text] [Related]
16. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
Hara T; Tanegashima K
Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
[TBL] [Abstract][Full Text] [Related]
17. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
Cabrero-de Las Heras S; Martínez-Balibrea E
World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues.
Meuter S; Moser B
Cytokine; 2008 Nov; 44(2):248-55. PubMed ID: 18809336
[TBL] [Abstract][Full Text] [Related]
19. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma Cells Secrete CXCL14 That Activates Integrin α11β1 on Fibroblasts to Form a Lung Metastatic Niche.
Xu Y; Deng C; Chen H; Song Y; Xu H; Song G; Wang X; Luo T; Chen W; Ma J; Zeng A; Huang S; Chen Z; Fu J; Gong M; Tai Y; Huang A; Feng H; Hu J; Zhu X; Tang Q; Lu J; Wang J
Cancer Res; 2024 Apr; 84(7):994-1012. PubMed ID: 38295227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
